Therapeutic interventions in acute stroke.

Por Lees, K R
Publicado em 1992

Treatment of cardiovascular diseases.

Por Lees, K R, Rubin, P C
Publicado em 1987

Haemodynamic and humoral effects of oral perindopril, an angiotensin converting enzyme inhibitor, in man.

Por Lees, K R, Reid, J L
Publicado em 1987

Lisinopril and nifedipine: no acute interaction in normotensives.

Por Lees, K R, Reid, J L
Publicado em 1988

Immunosuppressive treatment in stroke and renal failure.

Por Squire, I B, Grosset, D G, Lees, K R
Publicado em 1993

Influence of cholesterol on survival after stroke: retrospective study.

Por Dyker, A. G., Weir, C. J., Lees, K. R.
Publicado em 1997

Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.

Por MacFadyen, R J, Lees, K R, Reid, J L
Publicado em 1991

Double blind controlled study of low dose intravenous perindoprilat or enalaprilat infusion in elderly patients with heart failure.

Por MacFadyen, R J, Lees, K R, Reid, J L
Publicado em 1993

Responses to low dose intravenous perindoprilat infusion in salt deplete/salt replete normotensive volunteers.

Por MacFadyen, R J, Lees, K R, Reid, J L
Publicado em 1994

Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Por MacFadyen, R J, Lees, K R, Reid, J L
Publicado em 1991

Studies with low dose intravenous diacid ACE inhibitor (perindoprilat) infusions in normotensive male volunteers.

Por MacFadyen, R J, Lees, K R, Reid, J L
Publicado em 1992

Ethanol and platelet intracellular free calcium concentrations.

Por Lees, K R, Barr, S M, Butters, L, Rubin, P C
Publicado em 1987

Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteers.

Por Muir, K W, Grosset, D G, Gamzu, E, Lees, K R
Publicado em 1994

The pharmacokinetics and pharmacodynamics of perindopril in patients with hepatic cirrhosis.

Por Tsai, H H, Lees, K R, Howden, C W, Reid, J L
Publicado em 1989

Early clinical experience with the novel NMDA receptor antagonist CNS 5161

Por Walters, M R, Bradford, A P J, Fischer, J, Lees, K R
Publicado em 2002

Early clinical experience with the novel proteasome inhibitor PS–519

Por Shah, I M, Lees, K R, Pien, C P, Elliott, P J
Publicado em 2002

Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study.

Por Weir, C. J., Murray, G. D., Dyker, A. G., Lees, K. R.
Publicado em 1997

The antihypertensive efficacy and tolerability of a low dose combination of ramipril and felodipine ER in mild to moderate essential hypertension.

Por Bainbridge, A D, Macfadyen, R J, Stark, S, Lees, K R, Reid, J L
Publicado em 1993

Pharmacodynamic, pharmacokinetic and humoral effects of oral zabicipril, an angiotensin converting enzyme inhibitor in normotensive man.

Por MacDonald, N J, Hughes, D M, Lees, K R, Reid, J L
Publicado em 1990

A study of the acute pharmacodynamic interaction of ramipril and felodipine in normotensive subjects.

Por Bainbridge, A D, MacFadyen, R J, Lees, K R, Reid, J L
Publicado em 1991